All spinal muscular atrophy articles
-
Business
Novartis’ $8.7bn AveXis deal shows gene therapy appeal
Acquisition indicates the value of potentially permanent cures for inherited diseases
Acquisition indicates the value of potentially permanent cures for inherited diseases